BillionToOne, Inc.

Healthcare · Diagnostics & Research · United States

Last price 113.32 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 5.35B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and...